Skip to main content
Home

Call Us: 1-800-339-6484

    • Home
      • About Us
        • Mission & Values
        • NHOH In The News
        • Feedback
        • Career Opportunities
      • Our Team
        • Advance Practice Providers
        • Physicians
      • Locations & Directions
    • Office info
      • Your 1st Visit
      • Navigating Through The Office
      • Insurance Information
      • Affording Your Care
      • Refilling Your Prescription
      • HIPAA Notice
      • Referral Policy
      • Emergency Closing Information
      • Nondiscrimination Notice
    • Newly Diagnosed
      • What is Cancer?
      • Diagnosing Cancer
      • Intro to Cancer Treatments
      • Questions to Ask
      • A Word About Clinical Trials
      • The Role Of Caregivers
      • Types Of Cancer
      • Testing
    • Treatments
      • Chemotherapy
      • Radiation Therapy
      • Surgery
      • Hormonal Therapy
      • Targeted Therapy
      • Complementary & Alternative
      • Managing Side Effects
      • Support And Resources
    • Clinical Trials
      • Research Spotlight
      • What Are Clinical Trials?
      • Phases Of Clinical Trials
      • Participating In Clinical Trials
      • The Cost Of Clinical Trials
      • Open Clinical Trials
    • Hematology
      • What is Hematology?
      • Types Of Blood Diseases
      • Hematology Links
    • News

Cancer News

  • Cancer Grand Challenges announces global research funding opportunity with nine new challenges Wed, Mar 08 2023
    As part of the Cancer Grand Challenges program, NCI and Cancer Research UK have announced nine new research challenges to tackle profound problems in cancer research.
  • NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma Wed, Dec 28 2022
    A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma.
  • Statement from Monica M. Bertagnolli, M.D., Director, National Cancer Institute, National Institutes of Health Wed, Dec 14 2022
    A statement from the National Cancer Institute by NCI Director Monica M. Bertagnolli, M.D., about her recent diagnosis with early breast cancer.
    • Home
    • Newly Diagnosed
    • Your 1st Visit
    • Navigating NHOH
    • Insurance Information
    • Affording Your Care
    • Prescriptions
    • HIPAA Notice
    • Referral Policy
    • About Us
    • Our Team
    • Directions
    • Career Opportunities
    • Patient Bill Of Rights

Follow Us

Copyright © 2015- All Rights Reserved. Designed & Hosted by RightPath Media